Biller Scott Insider Trades

Insider Trading History

Track insider trading activity for Biller Scott. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $104k 25,000 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 25,000 shares
$4.79
$4.14
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $66.2k 16,000 shares
Last Trade
Jun 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.3k 16,000 shares
$5.52
$4.14
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $66.2k 16,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 16,000 shares
$8.70
$4.14
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $66.2k 16,000 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 16,000 shares
$13.81
$4.14
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $51.9k 12,530 shares
Last Trade
Jul 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 12,530 shares
$9.40
$4.14
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $0 0 shares
Last Trade
Oct 22, 2020 Sale
No data
No data
$4.14
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $1.2M 33,729 shares
Last Trade
Jun 11, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$353k 7,218 shares
$48.91
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Jun 11, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$353k 7,218 shares
$48.91
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $1.05M 29,511 shares
Last Trade
Apr 05, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$204k 3,000 shares
$68.10
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $1.41M 39,648 shares
Last Trade
Apr 05, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$204k 3,000 shares
$68.10
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $965k 27,110 shares
Last Trade
Apr 05, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$203k 3,000 shares
$67.71
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $1.52M 42,648 shares
Last Trade
Mar 05, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 3,000 shares
$67.29
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $1.04M 29,311 shares
Last Trade
Mar 05, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$203k 3,000 shares
$67.68
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $1.05M 29,511 shares
Last Trade
Mar 05, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 3,000 shares
$67.29
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $944k 26,511 shares
Last Trade
Feb 27, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$585k 9,000 shares
$65.00
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $419k 11,782 shares
Last Trade
Feb 27, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$586k 9,000 shares
$65.14
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $1.26M 35,511 shares
Last Trade
Feb 27, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$586k 9,000 shares
$65.14
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $1.42M 40,000 shares
Last Trade
Feb 22, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.94M 50,000 shares
$58.86
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $944k 26,511 shares
Last Trade
Feb 19, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$50.8k 876 shares
$58.03
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Scientific Officer
Holding Value $196k 5,500 shares
Last Trade
Feb 16, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$163k 2,750 shares
$59.29
$35.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up